2025 MedTech Innovator US Cohort Press Release

Octin Health, Inc. Selected for Prestigious MedTech Innovator 2025 Accelerator Cohort

— One of 65 startups chosen from nearly 1,500 global applicants —

— Selected to participate in the world’s leading medtech accelerator —

Edina, Minnesota – June 5, 2025 – Octin Health, a medical device company focused on decreasing the risk for aortic arch operations announced today that it has been selected to join the MedTech Innovator 2025 Accelerator Cohort. Octin Health is one of only 65 companies—representing the top 4% of nearly 1,500 global applicants—chosen for this year’s program.

MedTech Innovator (MTI) is the world’s largest accelerator for medical technology startups. The highly competitive four-month program provides participants with world-class mentorship, strategic guidance, and access to a robust network of investors, providers, payers, manufacturers, and industry experts.

“We are honored to join this year’s MedTech Innovator cohort,” said Meghana Helder, CEO of Octin Health. “This opportunity gives us a powerful platform to validate our technology, build key partnerships, and accelerate our path to market.”

Throughout the program, cohort companies will present at major industry events including The MedTech Conference powered by AdvaMed (October 5–8 in San Diego) and/or the MedTech Strategist Innovation Summit (November 19–21 in San Diego), where they will compete for a share of $800,000 in non-dilutive funding.

About Octin Health

Octin Health was founded in 2024 by Dr. Meghana Helder, a practicing cardiovascular surgeon, who is passionate about making aortic arch operations safer for patients. Octin Health is developing the Elika Device to eliminate the need for deep hypothermic circulatory arrest, improve efficiency and reduce healthcare costs for hospitals.

About MedTech Innovator

MedTech Innovator is the world’s largest accelerator of medical device, digital health, and diagnostic companies. Its mission is to improve human health by accelerating the growth of companies transforming patient care. MTI has been a catalyst for groundbreaking healthcare solutions, sourcing nearly 14,000 applicants and fostering the growth of over 700 graduates. Alumni have collectively raised $10 billion in follow-on funding and introduced 400+ products to the market, improving the health of millions worldwide. For more information about MedTech Innovator, its annual programs, portfolio of industry-leading startups, and insights on trends, visit MTI’s website, follow them on LinkedIn, and subscribe to its monthly newsletter.

Test Release Title

Heading 1 – blah blah blah

A test link

This is a test Heading 2

Lorem ipsum dolor sit amet, consectetur adipiscing elit. Integer vitae tellus vulputate, fermentum elit sed, auctor mauris. Donec tempus nisi ut tellus molestie, id commodo purus venenatis. Curabitur tempus odio lacus, quis gravida magna vestibulum vehicula. Donec sollicitudin diam non odio venenatis, sit amet bibendum massa tempus. In vel vulputate lorem. Aenean commodo porta justo, non suscipit justo consequat non. Maecenas sollicitudin elementum nisl, vel vulputate orci imperdiet id. Donec sollicitudin ex ut diam condimentum pellentesque. In sodales magna nec quam efficitur malesuada. Nulla eu fringilla nisl, ac luctus quam.

Ut mattis risus et nulla pharetra euismod. Curabitur congue nunc a enim dapibus porttitor. Integer semper, augue in aliquam posuere, neque ante sagittis nisi, sit amet dictum augue tellus sit amet enim. Mauris scelerisque sem risus. Vestibulum hendrerit consequat risus in iaculis. Nam pellentesque sit amet augue sit amet luctus. Etiam eros lacus, faucibus a tristique vitae, placerat sit amet turpis. Nulla fringilla purus nec massa tristique, ut ornare lorem malesuada. Pellentesque habitant morbi tristique senectus et netus et malesuada fames ac turpis egestas. Maecenas luctus augue et diam tincidunt luctus. Nullam at turpis non tortor accumsan commodo vitae nec felis. Donec nunc ante, ultrices sit amet orci id, mollis aliquam risus. Curabitur leo magna, condimentum tempor tincidunt non, congue at nulla.

Heading 3

Lorem ipsum dolor sit amet, consectetur adipiscing elit. Integer vitae tellus vulputate, fermentum elit sed, auctor mauris. Donec tempus nisi ut tellus molestie, id commodo purus venenatis. Curabitur tempus odio lacus, quis gravida magna vestibulum vehicula. Donec sollicitudin diam non odio venenatis, sit amet bibendum massa tempus. In vel vulputate lorem. Aenean commodo porta justo, non suscipit justo consequat non. Maecenas sollicitudin elementum nisl, vel vulputate orci imperdiet id. Donec sollicitudin ex ut diam condimentum pellentesque. In sodales magna nec quam efficitur malesuada. Nulla eu fringilla nisl, ac luctus quam.

This is a heading 4

Lorem ipsum dolor sit amet, consectetur adipiscing elit. Integer vitae tellus vulputate, fermentum elit sed, auctor mauris. Donec tempus nisi ut tellus molestie, id commodo purus venenatis. Curabitur tempus odio lacus, quis gravida magna vestibulum vehicula. Donec sollicitudin diam non odio venenatis, sit amet bibendum massa tempus. In vel vulputate lorem. Aenean commodo porta justo, non suscipit justo consequat non. Maecenas sollicitudin elementum nisl, vel vulputate orci imperdiet id. Donec sollicitudin ex ut diam condimentum pellentesque. In sodales magna nec quam efficitur malesuada. Nulla eu fringilla nisl, ac luctus quam.

 

Heading 5

 

Heading 6